Literature DB >> 25374689

Catalyst-free synthesis of highly biologically active 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol.

Dhruva Kumar1, Suresh Narwal1, Jagir S Sandhu1.   

Abstract

A green, efficient synthesis of 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives without using any external catalyst in polyethylene glycol (PEG) at 80°C has been described. Reaction procedure is very simple, short, and obtained yields are very high.

Entities:  

Year:  2013        PMID: 25374689      PMCID: PMC4207417          DOI: 10.1155/2013/273534

Source DB:  PubMed          Journal:  Int J Med Chem        ISSN: 2090-2077


1. Introduction

Rhodanines and thiazolidinediones both are aprivileged class of molecule, and they show large number of biological activities. The most significant position of these molecules seems to be as they are asubset of commercially employed noninsulin-dependent diabetes mellitus (NIDDM), insulin sensitizing agents (Figure 1) such as epalrestat, ciglitazone, AD-5061, pioglitazone, rosiglitazone, and so forth.
Figure 1

Clinically used molecules having 5-arylidene rhodanines and 2,4-thiazolidenediones.

Furthermore, rhodanine derivatives possess anticonvulsant, antibacterial, antiviral, and antidiabetic activities [1-3] Some of rhodanine-based derivatives act as hepatitis C virus (HCV) protease inhibitor [4], uridine diphospho-N-acetylmuramate/L-alanine ligase inhibitor [5], aldose reductase [6], β-lactamase [7], and JNK-stimulating phosphatase-1 (JSP-1) [8], while some of its derivatives are used for the analysis of certain noble metal ions [9]. Therefore, the synthesis of rhodanine derivatives currently is of much importance and a variety of methods and catalysts have been used [10-12]. Unlike rhodanine, 2,4-thiazolidinedione derivatives also have remarkable biological activities like antidiabetic [13], antibacterial [14], antifungal [15], antiproliferative effect on vascular smooth muscle [16], aldose reductase inhibitors [17], 15-hydroxyprostaglandin dehydrogenase inhibitors [18] instead of these biological activities 5-benzylidene-thiazolidine-2,4-dione derivatives act as inhibitors of MurD ligase [19]. In the literature several methods have been reported to synthesize these privileged molecules [20-24]. Therefore, significant biological activities prompt us to synthesize thiozolidine derivatives. Nitrones (imine oxides) are reputed as 1,3-dipoles and are extensively explored for the synthesis of five membered heterocycles by combining them with several types of multiple bonds [25-27]. Apart from this major utility their general chemistry is little studied.[27] There are few reports of successful 1,3-additions of nitrones [28, 29]. Yousif et al. reported reactions of heterocyclic N-oxides under acidic conditions and obtained only condensed products [30]. In contrast, their counterpart imines are extensively explored to expose their utility as aldehyde equivalent [31-33]. Present protocol is the environment benign synthesis of 5-arylidene rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol (PEG). The reaction proceeds via addition-elimination way and afforded the desire products in very good to excellent yield (Scheme 1).
Scheme 1

Synthesis of 5-arylidene thiazolidinediones.

2. Results and Discussion

First of all, a series of nitrones was prepared using a variety of aldehyde and hydroxyl amine as per already reported method [34]. A mixture of freshly prepared N-phenyl-N-phenylmethylidenamine oxide (10 mmol) 1a and rhodanine (10 mmol) 2a was stirred at 80°C in polyethylene glycol (PEG) for 20 min to afford corresponding arylidene rhodanine 3a   via addition-elimination process. To check the effect of the solvent, a set of reactions was performed using different solvents such as MeOH, EtOH, H2O, THF, PEG, DMF, and so forth and in absence of solvent. Conclusively, in case of PEG best results were obtained with high yields in minimum reduced time. Keeping optimized reaction conditions, a variety of aldehydes with rhodanine/2,4-thiazolidinedione were reacted to afford 5-arylidenerhodanines 3a–g and 5-arylidene-2,4-thiazolidinediones 3h–n with excellent yields (Table 1).
Table 1

Synthesis of 5-arylidine rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol (PEG).

EntryXYProducta Time (min)Yield (%)b Melting point (°C) reference
1HS 3a 2085202-203 [11]
24-ClS 3b 2093230–232 [11]
34-BrS 3c 2089229-230 [3]
4 4-NO2 S 3d 2594254-255 [11]
5 4-CH3 S 3e 3078224-225 [11]
6 4-CH3OS 3f 3083250-251 [11]
74-OHS 3g 3079184-185 [35]
8HO 3h 2592240-241 [36]
93-ClO 3i 2588270-271 [36]
104-ClO 3j 2585224-225 [37]
114-NO2 O 3k 2575260–262 [37]
124-CH3 O 3l 2586224-225 [37]
134-CH3OO 3m 3588234-235 [36]
144-OHO 3n 3590280-281 [36]

aReaction conditions: 1a–h (10 mmol), 2a-b (10 mmol), and polyethylene glycol (PEG) 5 mL were heated at 80°C on magnetic stirrer. The products were characterized by spectral techniques like IR, 1H NMR. bIsolated yields after recrystallization.

Active methylene compounds 2a–b afforded the Knoevenagel products 3a–n selectively with exo-double bond without the formation of other side-products/bis-products as shown in Scheme 2 via addition-elimination process. Electron withdrawing and donating groups on aromatic N-oxides showd slightly diversion in rate of reaction and yields; that is, electron withdrawing group containing aromatic N-oxides afforded arylidene compounds with better yields in shorter reaction time (Table 1).
Scheme 2

Plausible reaction mechanism.

Next, the recyclability of the solvent was studied by using 1a and 2a as the model substrates. We observed that PEG could be recovered by under vacuum filtration of products obtained on cooling. PEG recovered as filtrate and was successfully recycled and reused for five runs. As far as mechanism is concerned, reaction proceeds via nucleophilic addition of 2 on 1 with subsequent elimination of amine part of aromatic N-oxides to afford arylidene products 3 (Scheme 2).

3. Conclusion

In summary, the present protocol is an efficient and environmentally benign procedure for the synthesis of drug intermediate 5-arylidine rhodanine and 2,4-thiazolidinedione derivatives using aldonitrones in polyethylene glycol (PEG) via simple addition-elimination process. Present protocol does not need any external catalyst, and it is applicable on a variety of nitrones. This method produces good to excellent yields in shorter reaction time, and it seems that reaction is autocatalyzed because eliminatingpart of nitrone acts as catalyst.

4. Experimental Section

4.1. General

Reagent-grade chemicals were purchased from a commercial source and used without further purification. Yields refer to the yield of the isolated products. Melting points were determined in open capillaries in paraffin bath and are uncorrected. Infrared (IR) spectra were recorded in KBr discs on a Perkin-Elmer 240C analyzer. 1H NMR spectra were recorded on a BRUKER AVANCE II 400 NMR Spectrometer using tetramethylsilane (TMS) as internal standard. The progress of the reaction was monitored by thin layer chromatography (TLC) using silica gel G (Merck).

4.2. General Method for the Synthesis of 5-Arylidene Rhodanine and 2,4-Thiazolidinedione (3a–n)

A mixture-nitrone (10 mmol) 1, rhodanine or 2,4-thiazolidinedione (10 mmol) 2, and polyethylene glycol (5 mL) was stirred at 80°C temperature for appropriate time (see Table 1). Reaction progress was monitored via TLC. After reaction completion, crude product was precipitated out on cooling. Obtained product was filtered, dried, and for further purification recrystallized from ethanol-DMF.

4.3. Spectral Data of Reprehensive Compounds

(5Z)-5-Benzylidene-2-thioxo-1,3-thiazolidine-4-one (3a): IR (KBr): 3390, 1709, 1669, 1600, 1429, 1200 cm−1. 1H NMR (300 MHz, DMSO-d6) δ H: 13.57 (s, 1H, NH), 7.68 (s, 1H, =CH), 7.48–7.79 (m, 5H, Ar–H). (5Z)-5-(4-Methoxybenzylidene)-2-thioxo-1,3-thiazolidine-4-one (3f): 1H NMR (300 MHz, DMSO-d6) δ H: 13.71 (s, 1H, NH), 7.61 (s, 1H, =CH), 7.52 (d, 2H, j = 8.2 Hz, Ar–H), 7.08 (d, 2H, j = 8.2 Hz, Ar–H), 3.09 (s, 3H, OCH3). (5Z)-5-Benzylidene-1,3-thiazolidine-2,4-dione (3h): IR (KBr) cm−1:  3155 (NH), 3049, 879 (CH; aromatic), 2868 (CH; aliphatic), 1739, 1691 (C=O). 1H NMR (300 MHz, DMSO-d6) δ H: 8.27 (1H, s, NH), 7.86 (1H, s, CH), 7.26 (5H, m, aromatic protons). MS m/z (%): 206 (M + 1). (5Z)-5-(4-Methylbenzylidene)-1,3-thiazolidine-2,4-dione (3m): IR (KBr) 3211, 1725, 1689 cm−1. 1H NMR (300 MHz, DMSO-d6) δ H: 12.50 (s, 1H, br, NH), 7.69 (s, 1H, =CH), 7.50 (d, 2H, j = 8.3 Hz, Ar–H), 7.11 (d, 2H, j = 8.3 Hz, Ar–H), 3.49 (s, 3H, OCH3).
  17 in total

1.  Rhodanine derivatives as inhibitors of JSP-1.

Authors:  Neil S Cutshall; Christine O'Day; Marina Prezhdo
Journal:  Bioorg Med Chem Lett       Date:  2005-07-15       Impact factor: 2.823

2.  Enantioselective addition of ketene silyl acetals to nitrones catalyzed by chiral titanium complexes. Synthesis of optically active beta-amino acids.

Authors:  Shun-Ichi Murahashi; Yasushi Imada; Toru Kawakami; Kazuhito Harada; Yoshiharu Yonemushi; Naomi Tomita
Journal:  J Am Chem Soc       Date:  2002-03-27       Impact factor: 15.419

3.  Benzylidene rhodanines as novel inhibitors of UDP-N-acetylmuramate/L-alanine ligase.

Authors:  Mui Mui Sim; Siew Bee Ng; Antony David Buss; Sharon Carmelita Crasta; Kah Lin Goh; Sue Kim Lee
Journal:  Bioorg Med Chem Lett       Date:  2002-02-25       Impact factor: 2.823

4.  Synthesis and antifungal activity of (Z)-5-arylidenerhodanines.

Authors:  Maximiliano Sortino; Paula Delgado; Sabina Juárez; Jairo Quiroga; Rodrigo Abonía; Braulio Insuasty; Manuel Nogueras; Laura Rodero; Francisco M Garibotto; Ricardo D Enriz; Susana A Zacchino
Journal:  Bioorg Med Chem       Date:  2006-10-16       Impact factor: 3.641

5.  In vitro evaluation of 5-arylidene-2-thioxo-4-thiazolidinones active as aldose reductase inhibitors.

Authors:  Rosanna Maccari; Antonella Del Corso; Marco Giglio; Roberta Moschini; Umberto Mura; Rosaria Ottanà
Journal:  Bioorg Med Chem Lett       Date:  2010-11-12       Impact factor: 2.823

6.  Synthesis and biological evaluation of novel thiazolidinedione analogues as 15-hydroxyprostaglandin dehydrogenase inhibitors.

Authors:  Ying Wu; Sandeep Karna; Cheol Hee Choi; Min Tong; Hsin-Hsiung Tai; Dong Hee Na; Chul Ho Jang; Hoon Cho
Journal:  J Med Chem       Date:  2011-06-29       Impact factor: 7.446

7.  The synthesis and SAR of rhodanines as novel class C beta-lactamase inhibitors.

Authors:  E B Grant; D Guiadeen; E Z Baum; B D Foleno; H Jin; D A Montenegro; E A Nelson; K Bush; D J Hlasta
Journal:  Bioorg Med Chem Lett       Date:  2000-10-02       Impact factor: 2.823

8.  Synthesis and aldose reductase inhibitory activity of 5-arylidene-2,4-thiazolidinediones.

Authors:  G Bruno; L Costantino; C Curinga; R Maccari; F Monforte; F Nicoló; R Ottanà; M G Vigorita
Journal:  Bioorg Med Chem       Date:  2002-04       Impact factor: 3.641

9.  [[omega-(Heterocyclylamino)alkoxy]benzyl]-2,4-thiazolidinediones as potent antihyperglycemic agents.

Authors:  B C Cantello; M A Cawthorne; G P Cottam; P T Duff; D Haigh; R M Hindley; C A Lister; S A Smith; P L Thurlby
Journal:  J Med Chem       Date:  1994-11-11       Impact factor: 7.446

10.  Studies on the synthesis of 5-(p-aminobenzylidene)-rhodanine and its properties.

Authors:  E Tang; Guangyu Yang; Jiayuan Yin
Journal:  Spectrochim Acta A Mol Biomol Spectrosc       Date:  2003-02       Impact factor: 4.098

View more
  2 in total

1.  Harnessing ROS-Induced Oxidative Stress for Halting Colorectal Cancer via Thiazolidinedione-Based SOD Inhibitors.

Authors:  Mohamed Nabil Abd Al Moaty; El Sayed H El Ashry; Laila Fathy Awad; Asmaa Mostafa; Marwa M Abu-Serie; Mohamed Teleb
Journal:  ACS Omega       Date:  2022-06-07

2.  Environmentally Friendly Approach to Knoevenagel Condensation of Rhodanine in Choline Chloride: Urea Deep Eutectic Solvent and QSAR Studies on Their Antioxidant Activity.

Authors:  Maja Molnar; Harshad Brahmbhatt; Vesna Rastija; Valentina Pavić; Mario Komar; Maja Karnaš; Jurislav Babić
Journal:  Molecules       Date:  2018-07-29       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.